NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
TrumpTariffTradeAnnounceLaunchNewsPricesStrikesMajorFebruaryPhotosYourCarLotSayCourtDigestSundayTimelineSafetyGlobalMarketTechChina
TrumpTariffTradeAnnounceLaunchNewsPricesStrikesMajorFebruaryPhotosYourCarLotSayCourtDigestSundayTimelineSafetyGlobalMarketTechChina
All Articles
Biotechnology Market | Research Report , Key Forces Shaping the Next Decade of Growth by 2029
pharmiweb.com
Published 2 days ago

Biotechnology Market | Research Report , Key Forces Shaping the Next Decade of Growth by 2029

pharmiweb.com · Feb 20, 2026 · Collected from GDELT

Summary

Published: 20260220T150000Z

Full Article

Biotechnology Market Overview: The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth include advancements in genetic engineering and genomics, an increasing demand for biopharmaceuticals, the rising prevalence of chronic diseases, expansion in environmental and agricultural biotechnology, greater investment in research and development, a surge in demand for synthetic biology, and supportive government policies. Download Sample Copy: https://meditechinsights.com/biotechnology-market/request-sample/ Biotechnology is a scientific field that harnesses biological organisms, systems, or processes to create products and technologies that improve health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology drives innovations such as genetic engineering, biopharmaceuticals, biofuels, and genetically modified organisms (GMOs). This field plays a crucial role in developing disease therapies, enhancing crop resilience, and fostering eco-friendly industrial practices. Emerging technologies like gene editing, synthetic biology, and regenerative medicine are further expanding biotechnology’s impact, offering solutions to global challenges in healthcare, food security, and sustainable resource management. Competitive Landscape Analysis The global biotechnology market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Novartis AG, Biogen, Abbott, Pfizer Inc., Amgen Inc., Novo Nordisk A/S, and Merck KGaA; among others. Some of the key strategies adopted by market players include new product and service development, strategic partnerships and collaborations, and geographic expansion. Download Sample Copy: https://meditechinsights.com/biotechnology-market/request-sample/ Advancements in Genetic Engineering and Genomics Fuel Market Demand Advancements in genetic engineering and genomics are driving significant growth in the biotechnology market by enabling precise genetic modifications. These innovations are paving the way for breakthroughs in personalized medicine, gene therapies, and biopharmaceuticals. Techniques such as CRISPR-Cas9 and next-generation sequencing (NGS) have revolutionized disease treatment and prevention, allowing for targeted therapies tailored to individual genetic profiles. These technologies are also enabling the development of treatments for previously untreatable diseases and enhancing crop resilience in agriculture. Additionally, genomics-based data analytics are streamlining drug discovery and development, reducing both R&D costs and time-to-market. This precision and efficiency are attracting considerable investments across the biotechnology sector. Growing Demand for Biopharmaceuticals Driving Market Growth The rising demand for biopharmaceuticals is a key factor propelling the biotechnology market forward. Biologic drugs, such as monoclonal antibodies, vaccines, and cell therapies, offer targeted treatments with fewer side effects compared to traditional pharmaceuticals. These therapies are especially effective in treating complex, chronic diseases like cancer, autoimmune disorders, and genetic conditions. The growing efficacy and specificity of biopharmaceuticals are fueling global demand, prompting biopharma companies to increase R&D investments. Furthermore, advancements in biotechnology—such as recombinant DNA technology and cutting-edge bio-manufacturing processes—are enabling more efficient production of biopharmaceuticals, accelerating market growth and the development of personalized, high-impact treatments. Browse Research Report: https://meditechinsights.com/biotechnology-market/ Market Segmentation This report by Medi-Tech Insights provides the size of the global biotechnology market at the regional- and country-level from 2022 to 2029. The report further segments the market based on technology, application, and offering. Market Size & Forecast (2022-2029), By Technology, USD Million Nanobiotechnology Tissue Engineering and Regenerative Medicine DNA Sequencing and Genomics Cell-based Assays Fermentation Technology PCR Technology Chromatography CRISPR and Gene Editing Synthetic Biology Cell and Gene Therapy Bioinformatics Others Market Size & Forecast (2022-2029), By Application, USD Million Healthcare and Medical Biotechnology Agricultural Biotechnology Industrial Biotechnology Environmental Biotechnology Others Market Size & Forecast (2022-2029), By Offering, USD Million Biopharmaceuticals Bio-services Bio-agriculture Products Bio-industrial Products Diagnostic and Research Reagent Others Market Size & Forecast (2022-2029), By Region, USD Million North America US Canada Europe UK Germany France Italy Spain Rest of Europe Asia Pacific China India Japan Rest of Asia Pacific Latin America Middle East & Africa Related Report: Injectable Drug Delivery Market https://www.pharmiweb.com/press-release/2026-02-19/injectable-drug-delivery-market-research-2026-analysis-size-share-growth-by-region-and-forecast-to-2031 Surgical Staplers Market https://www.pharmiweb.com/press-release/2026-02-19/surgical-staplers-market-research-report-analysis-size-share-demand-by-region-and-forecast-to-2031 AI-based Clinical Trials Solution Provider Market https://www.pharmiweb.com/press-release/2026-02-19/ai-based-clinical-trials-solution-provider-market-poised-for-innovation-and-global-expansion-through-2030 FemTech Market https://www.pharmiweb.com/press-release/2026-02-19/femtech-market-research-report-analysis-share-size-demand-by-region-and-forecast-2030 Dialysis Market https://www.pharmiweb.com/press-release/2026-02-19/dialysis-market-size-share-growth-trends-and-research-report-forecast-2026-2030 About Medi-Tech Insights ; Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers. Contact: Ruta Halde Associate, Medi-Tech Insights +32 498 86 80 79 info@meditechinsights.com


Share this story

Read Original at pharmiweb.com

Related Articles

pharmiweb.com4 days ago
Flashpoint Therapeutics Announces Major Publication on Novel HPV Cancer Vaccine

Published: 20260218T060000Z

pharmiweb.com5 days ago
GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance arti

Published: 20260217T201500Z

pharmiweb.com6 days ago
Sygnature Discovery Unveils Strategic Rebrand to Cement Status as a Global Drug Discovery Partner

Published: 20260216T210000Z

South China Morning Postabout 7 hours ago
Why the Fed credibility crisis will hit emerging markets harder

As political pressure on the US Federal Reserve intensifies in Washington, the reverberations are rippling across the globe. Gregory Peters, co-chief investment officer of fixed income at PGIM, has noted that bringing political pressure to bear on the Fed is an “own goal” – a self-inflicted shock that erodes confidence and is unlikely to deliver lower borrowing costs for the US. This reassessment – marked by quiet “sell America” trades – is beginning to surface. The damage extends far beyond...

Financial Timesabout 11 hours ago
Earnings and AI fears drive ‘extreme’ churn in US stock market

Gap between large moves in individual equities and subdued index performance hits highest since global financial crisis

Hacker News1 day ago
CXMT has been offering DDR4 chips at about half the prevailing market rate

Article URL: https://www.koreaherald.com/article/10679206 Comments URL: https://news.ycombinator.com/item?id=47101171 Points: 17 # Comments: 5